Literature DB >> 14752880

Medulloblastoma in childhood: Impact of radiation technique upon the outcome of treatment.

Marzanna Chojnacka1, Anna Skowrońska-Gardas.   

Abstract

BACKGROUND: Medulloblastoma is an infratentorial primitive neuroectodermal tumour, diagnosed in paediatric population. The radiotherapy is an essential method of treatment for these tumours. The impact of technical quality of radiation therapy on survival was recently considered. In this study treatment-related variables are analysed with a special focus on radiotherapy technical factors. PROCEDURE: The population of 158 children with a diagnosis of medulloblastoma had been undergoing postoperative radiotherapy at MCMCC in Warsaw in the period 1983-1997. The medical data of these patients were analysed. Simulation films of the whole-brain irradiation fields were retrospectively reviewed at 112 patients. The distance from the field margin to the cribriform plate and to the floor of the temporal fossa was assessed and correlated with supratentorial relapse.
RESULTS: Five-year overall survival (OS) and 5-year disease free survival (DFS) were 46% and 40%, respectively. In multivariate analysis gender (P = 0.008), neurological status before radiotherapy (P = 0.029), M-stage (P < 0.001) and sequence of craniospinal irradiation (P = 0.019) were significant prognostic factors for OS. For DFS significant factors were M-stage (P < 0.001) and neurological status (P < 0.001). The cranial fields were not fully correctly covered at 43% patients. The field incorrectness was correlated with isolated supratentorial failure (P = 0.049).
CONCLUSIONS: Our results are similar to those published in literature. M0-stage was the most powerful favourable prognostic factor. Male gender and neurological status before radiation treatment were associated with poor survival. Also protracted radiotherapy and quality of radiation technique may have an impact on the outcome. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14752880     DOI: 10.1002/pbc.10401

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  6 in total

1.  Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.

Authors:  Thomas E Merchant; Larry E Kun; Matthew J Krasin; Dana Wallace; Murali M Chintagumpala; Shiao Y Woo; David M Ashley; Maree Sexton; Stewart J Kellie; Verity Ahern; Amar Gajjar
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-24       Impact factor: 7.038

2.  Fast imaging employing steady-state acquisition (FIESTA) MRI to investigate cerebrospinal fluid (CSF) within dural reflections of posterior fossa cranial nerves.

Authors:  David J Noble; Daniel Scoffings; Thankamma Ajithkumar; Michael V Williams; Sarah J Jefferies
Journal:  Br J Radiol       Date:  2016-09-29       Impact factor: 3.039

3.  Reirradiation of recurrent medulloblastoma: does clinical benefit outweigh risk for toxicity?

Authors:  Cynthia Wetmore; Danielle Herington; Tong Lin; Arzu Onar-Thomas; Amar Gajjar; Thomas E Merchant
Journal:  Cancer       Date:  2014-07-30       Impact factor: 6.860

4.  Craniospinal radiotherapy in children: Electron- or photon-based technique of spinal irradiation.

Authors:  Marzanna Chojnacka; Anna Skowrońska-Gardas; Marzena Morawska-Kaczyńska; Anna Zygmuntowicz-Piętka; Katarzyna Pędziwiatr; Anna Semaniak
Journal:  Rep Pract Oncol Radiother       Date:  2010-02-18

5.  Field-in-Field Technique With Intrafractionally Modulated Junction Shifts for Craniospinal Irradiation Planning With Three-Dimensional Conformal Radiation Therapy.

Authors:  Shabbir Hussain; Abdul Hafeez; Hira Nazim; Rahim Gohar; Muhammad Jawaid Mallick
Journal:  Cureus       Date:  2021-04-28

6.  Highly Conformal Craniospinal Radiotherapy Techniques Can Underdose the Cranial Clinical Target Volume if Leptomeningeal Extension through Skull Base Exit Foramina is not Contoured.

Authors:  D J Noble; T Ajithkumar; J Lambert; I Gleeson; M V Williams; S J Jefferies
Journal:  Clin Oncol (R Coll Radiol)       Date:  2017-03-18       Impact factor: 4.126

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.